REQUEST A DEMO
Total
USD $0.00
Search more companies

Evah Pharmaceutical S.A.S. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Evah Pharmaceutical S.A.S. Profile Updated: June 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Evah Pharmaceutical S.A.S. is based in Ecuador. The head office is in Cuenca. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on October 11, 2022. Evah Pharmaceutical S.A.S. currently employs 2 (2024) people. There was a net sales revenue increase of 3628.95% reported in Evah Pharmaceutical S.A.S.’s latest financial highlights for 2024. Over the same period, its total assets grew by 7950.27%. The enterprise’s net profit margin increased by 31.79% in 2024.

Headquarters
Av. Huayna Capac, 2-35
Cuenca; Azuay;

Contact Details: Purchase the Evah Pharmaceutical S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Evah Pharmaceutical S.A.S. report to view the information.
Registered Capital:
Purchase the Evah Pharmaceutical S.A.S. report to view the information.
Financial Auditors:
Purchase the Evah Pharmaceutical S.A.S. report to view the information.
Incorporation Date:
October 11, 2022
Key Executives
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Evah Pharmaceutical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
3628.95%
Total operating revenue
3628.95%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
8906.57%
Total Assets
7950.27%
Total Equity
7845.97%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
31.79%
Return on Equity (ROE)
6.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?